Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for Medline Inc.?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2023–2025
Key Multi-Year Facts
- Revenue moved from $23.23B in FY2023 to $28.43B in FY2025 (2-year CAGR +10.6%).
- Operating cash flow was below half of net income in FY2025.
Latest 3 Fiscal Years
| Fiscal Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue (USD B) | 23.2 | 25.5 | 28.4 |
| YoY | — | 9.8% | 11.5% |
| Net Income (USD B) | — | — | 1157 |
| Operating Cash Flow (USD B) | 1.69 | 1.77 | 1.74 |
| ROE | — | — | 10775.8% |
| Gross Margin | 25.3% | 27.3% | 26.4% |
| Net Margin | — | — | 4069.4% |
| Debt-to-Assets | — | 54.1% | 49.9% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-10
Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).
Items Flagged for Review
- Alert
-
Watch
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) 0.00
FY2025 (ended 2025-12-31) · What is this?
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?
Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.